Paper41969646
Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery.
Wu Y and 9 others. Bioact Mater, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery. Papers, record 41969646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41969646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References190
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40471243 | Advancing pulmonary therapy: the role of dry powder inhalation technology in lung disease management. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40471243 | PubMed |
| 2 | 32540976 | Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32540976 | PubMed |
| 3 | 35112802 | Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35112802 | PubMed |
| 4 | 38181690 | APTES-mediated Cu2(OH)3(NO3) nanomaterials on the surface of silicone catheters for abscess. | Colloids Surf B Biointerfaces | 2024 | https://conductscience.org/library/papers/38181690 | PubMed |
| 5 | 39469425 | Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles. | J Pharm Pharm Sci | 2024 | https://conductscience.org/library/papers/39469425 | PubMed |
| 6 | 37657277 | Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation. | Biomater Adv | 2023 | https://conductscience.org/library/papers/37657277 | PubMed |
| 7 | 37214258 | Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells. | Bioact Mater | 2023 | https://conductscience.org/library/papers/37214258 | PubMed |
| 8 | 38708178 | Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road? | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38708178 | PubMed |
| 9 | 37622289 | Wet-adhesive γ-PGA/ε-PLL hydrogel loaded with EGF for tracheal epithelial injury repair. | J Mater Chem B | 2023 | https://conductscience.org/library/papers/37622289 | PubMed |
| 10 | 27418577 | Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27418577 | PubMed |
| 11 | 38711938 | A multifunctional ionic liquid coating on 3D-Printed prostheses: Combating infection, promoting osseointegration. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/38711938 | PubMed |
| 12 | 38699242 | Macrophage based drug delivery: Key challenges and strategies. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38699242 | PubMed |
| 13 | 35513402 | Microwave assisted antibacterial action of Garcinia nanoparticles on Gram-negative bacteria. | Nat Commun | 2022 | https://conductscience.org/library/papers/35513402 | PubMed |
| 14 | 34015383 | Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review. | J Infect | 2021 | https://conductscience.org/library/papers/34015383 | PubMed |
| 15 | 41282407 | An inhalable gallium-polyphenol nanoparticle blocks bacterial electron transport chain and signal transduction for anti-biofilm therapy. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41282407 | PubMed |
| 16 | 38698403 | Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38698403 | PubMed |
| 17 | 39061312 | In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39061312 | PubMed |
| 18 | 34332109 | Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics. | Clin Microbiol Infect | 2022 | https://conductscience.org/library/papers/34332109 | PubMed |
| 19 | 39737874 | Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic-ROS Inflammation in Acute Lung Injury. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39737874 | PubMed |
| 20 | 31898875 | Polymyxin B-Polysaccharide Polyion Nanocomplex with Improved Biocompatibility and Unaffected Antibacterial Activity for Acute Lung Infection Management. | Adv Healthc Mater | 2020 | https://conductscience.org/library/papers/31898875 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42667161 | A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation-Induced Lung Injury by Targeting Ferroptosis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42667161 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41969646
GET https://conductscience.org/api/papers/v1/41969646/references?page=2